|
Report Date : |
07.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
UNITED PHARMACEUTICALS MANUFACTURING CO LTD
(UPM) |
|
|
|
|
Registered Office : |
Khalidi Hospital
Street, 3rd Circle, Jabal Amman, P O Box 69, Amman 11591 |
|
|
|
|
Country : |
Jordan |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
08.06.1989 |
|
|
|
|
Com. Reg. No.: |
2161, Amman |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers of pharmaceutical preparations |
|
|
|
|
No. of Employees : |
450 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Jordan |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Jordan - ECONOMIC OVERVIEW
Jordan's economy is among the smallest in the Middle East, with insufficient supplies of water, oil, and other natural resources, underlying the government''s heavy reliance on foreign assistance. Other economic challenges for the government include chronic high rates of poverty, unemployment, inflation, and a large budget deficit. Since assuming the throne in 1999, King ABDALLAH has implemented significant economic reforms, such as opening the trade regime, privatizing state-owned companies, and eliminating some fuel subsidies, which in the last decade spurred economic growth by attracting foreign investment and creating some jobs. The global economic slowdown and regional turmoil, however, have depressed Jordan''s GDP growth, impacting export-oriented sectors, construction, and tourism. In 2011 the government approved two economic relief packages and a budgetary supplement, largely to improve the living conditions for the middle and poor classes. Jordan''s finances have also been strained by a series of natural gas pipeline attacks in Egypt, causing Jordan to substitute more expensive heavy fuel oils to generate electricity. An influx of foreign aid, especially from Gulf countries, has helped to somewhat offset these extrabudgetary expenditures, but the budget deficit is likely to remain high, at nearly 10% of GDP excluding grants. Amman likely will continue to depend heavily on foreign assistance to finance the deficit in 2012. Jordan''s financial sector has been relatively isolated from the international financial crisis because of its limited exposure to overseas capital markets. Jordan is currently exploring nuclear power generation to forestall energy shortfalls.
|
Source : CIA |
Company Name : UNITED PHARMACEUTICALS MANUFACTURING CO LTD (UPM)
Country of Origin : Jordan
Legal Form : Limited Liability Company
Registration Date : 8th June 1989
Commercial Registration Number : 2161, Amman
Membership Number : 5950
National ID Number : 200004648
Issued Capital : JD 3,000,000
Paid up Capital : JD 3,000,000
Total Workforce : 450
Activities : Manufacturers of pharmaceutical preparations.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Person Interviewed : Mohammad Abu Jamoos, Finance Manager
UNITED PHARMACEUTICALS MANUFACTURING CO LTD
(UPM)
Registered &
Physical Address
Street : Khalidi Hospital Street
Area : 3rd Circle, Jabal
Amman
PO Box : 69
Town : Amman 11591
Country : Jordan
Telephone : (962-6) 4640771
Facsimile : (962-6) 4652386
Mobile : (962-79) 5699009
Email : info@upm.com.jo / khaledom@upm.com.jo / mohammadaj@upm.com.jo
Premises
Subject operates
from a medium sized suite of offices that are owned and located in the Central
Business Area of Amman.
Branch Office
(s)
Location Description
·
Al
Raqeem Factory
premises covering 29,000 sq metres
Sahab
Tel: (962-6) 4162901 / 4162906
Fax: (962-6) 4162905
Name Position
·
Munjid
Munir Sukhtian Chairman
·
Nidal
Munir Sukhtian Vice
Chairman
·
Ghayyath
Munir Sukhtian Director
·
Marlin
Nicola Sukhtian Director
·
Rana
Nidal Sukhtian Director
·
Dima
Nidal Sukhtian Director
·
Dara
Nidal Sukhtian Director
·
Onoud
Nidal Sukhtian Director
·
Dr Khaled Al Otaibi Marketing
Manager
·
Mohamed
Al Agbar Technical
Manager
·
Abdul Moniem Al Ali Sales
Manager
·
Mohammad Abu Jamoos Finance
Manager
Date of Establishment : 8th
June 1989
Legal Form :
Limited Liability Company
Commercial Reg. No. : 2161, Amman
Membership No. : 5950
National ID No. :
200004648
Issued Capital : JD 3,000,000
Paid up Capital : JD 3,000,000
Name of Shareholder
(s) Percentage
·
Munjid
Munir Sukhtian 33.3%
·
Ghayyath
Munir Sukhtian 33.3%
·
Nidal
Munir Sukhtian 5.5%
·
Marlin
Nicola Sukhtian 5.5%
·
Rana
Nidal Sukhtian 5.5%
·
Dima
Nidal Sukhtian 5.5%
·
Dara
Nidal Sukhtian 5.5%
·
Onoud
Nidal Sukhtian 5.5%
·
Amana Tourism Services
·
Arabian
Office Automation Company Ltd
·
Beit Jala Pharmaceutical Manufacturing (BJP)
·
Exir
LLC
·
Ghayat Construction
·
Households
& Toiletries Manufacturing Co
·
Jordan Greenhouses Manufacturing Co Ltd (Rayyan)
·
Munir Sukhtian Global
·
Munir Sukhtian Investment
·
Munir Sukhtian Trading Group Co Ltd
·
Sukhtian Brothers
·
Sukhtian Industrial Trading (SIT)
·
Tabuk Pharmaceutical Manufacturing Company
·
M S
Pharma
Amman
Activities: Engaged in the manufacture of
pharmaceutical preparations.
Subject produces 216
pharmaceutical products of which 44 are produced under license for
multinational
companies. The company has also a
manufacturing contract for 20 products to other companies.
Production Capacities:
|
Dosage Form |
Annum |
|
Capsule ( Powder & Hard Gelatin ) |
135,000,000 Cap |
|
Capsule (Pellets) |
50,000,000 Cap |
|
Semisolid Line ( Cream, Gel ,Ointment ) |
1,800,000 Tube |
|
Suspension & Dry Suspension |
500,000 Bottle |
|
Shampoo |
750,000 Bottle |
|
Soft Gelatin Capsule |
18,000,000 Cap |
|
Liquid Line ( Syrup ) |
2,500,000 Bottle |
|
Suppository |
1,200,000 Supp. |
|
Tablet |
180,000,000 Tab |
Import
Countries: Germany,
Belgium, France, Italy and the United Kingdom.
International
Suppliers:
·
Astra Romania
·
Hiba
Drugstore Sudan
·
U
Carbon Austria
Export
Countries: Iraq, Saudi Arabia,
United Arab Emirates, Qatar, Bahrain, Oman, Kuwait, Yemen, Lebanon, Libya, Algeria, Egypt, Sudan, Ethiopia, Germany,
Romania, Kazakhstan, Hong Kong, Malaysia and the Philippines.
Operating Trend: Steady
Subject has a
workforce of approximately 450 employees.
Financial
highlights provided by local sources are given below:
Currency: Jordanian
Dinars (JD)
Year
Ending 31/12/11: Year
Ending 31/12/12:
Total Sales JD 17,000,000 JD 17,650,000
Local sources consider
subject’s financial condition to be Fair.
The above figures
were provided by Mr Mohammad Abu Jamoos, Finance Manager
·
Arab
Bank Plc
Shmeisani Branch
PO Box: 950545 & 950544
Amman 11195
Tel: (962-6) 5607231 / 5607115
Fax: (962-6) 5606793 / 5606830
No complaints
regarding subject’s payments have been reported.
Amount overdue 0
Payment terms 60
days
Payment Method Letters
of Credit
Paying record No
Complaints
Currency US
Dollars
According to local
sources, subject meets its payment obligations in a timely manner and the
business is considered to be a fair trade risk.
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.71 |
|
UK Pound |
1 |
Rs.82.79 |
|
Euro |
1 |
Rs.71.43 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.